The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Bauer, Henrik C F
Sundby Hall, Kirsten
Vult Von Steyern, Fredrik
Egil Eide, Geir
Alvegard, Thor A
MetadataShow full item record
CitationThe Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma. 2017, 88 (3):341-347 Acta Orthop
AbstractPurpose - We wanted to examine the potential of the Scandinavian Sarcoma Group (SSG) Central Register, and evaluate referral and treatment practice for soft-tissue sarcomas in the extremities and trunk wall (STS) in the Nordic countries. Background - Based on incidence rates from the literature, 8,150 (7,000-9,300) cases of STS of the extremity and trunk wall should have been diagnosed in Norway, Finland, Iceland, and Sweden from 1987 through 2011. The SSG Register has 6,027 cases registered from this period, with 5,837 having complete registration of key variables. 10 centers have been reporting to the Register. The 5 centers that consistently report treat approximately 90% of the cases in their respective regions. The remaining centers have reported all the patients who were treated during certain time periods, but not for the entire 25-year period. Results - 59% of patients were referred to a sarcoma center untouched, i.e. before any attempt at open biopsy. There was an improvement from 52% during the first 5 years to 70% during the last 5 years. 50% had wide or better margins at surgery. Wide margins are now achieved less often than 20 years ago, in parallel with an increase in the use of radiotherapy. For the centers that consistently report, 97% of surviving patients are followed for more than 4 years. Metastasis-free survival (MFS) increased from 67% to 73% during the 25-year period. Interpretation - The Register is considered to be representative of extremity and trunk wall sarcoma disease in the population of Scandinavia, treated at the reporting centers. There were no clinically significant differences in treatment results at these centers.
DescriptionTo access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Files
RightsArchived with thanks to Acta orthopaedica
- Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project.
- Authors: Trovik CS, Scanadinavian Sarcoma Group Project.
- Issue date: 2001 Feb
- Monitoring referral and treatment in soft tissue sarcoma: study based on 1,851 patients from the Scandinavian Sarcoma Group Register.
- Authors: Bauer HC, Trovik CS, Alvegård TA, Berlin O, Erlanson M, Gustafson P, Klepp R, Möller TR, Rydholm A, Saeter G, Wahlström O, Wiklund T
- Issue date: 2001 Apr
- The Scandinavian Sarcoma Group Register.
- Authors: Bauer HC, Alvegård TA, Berlin O, Erlanson M, Gustafson P, Kivioja A, Klepp R, Lehtinen T, Lindholm P, Möller TR, Rydholm A, Saeter G, Trovik CS, Wahlström O, Wiklund T
- Issue date: 1999 Jun
- Soft tissue sarcoma. Epidemiology and prognosis in 508 patients.
- Authors: Gustafson P
- Issue date: 1994 Jun
- Prognostic factors and follow-up strategy for superficial soft-tissue sarcomas: Analysis of 622 surgically treated patients from the scandinavian sarcoma group register.
- Authors: Tsagozis P, Bauer HC, Styring E, Trovik CS, Zaikova O, Brosjö O
- Issue date: 2015 Jun